Article Versions Notes

Santos ALS, Braga-Silva LA, Gonçalves DS, Ramos LS, Oliveira SSC, Souza LOP, Oliveira VS, Lins RD, Pinto MR, Muñoz JE, et al. Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches. Journal of Fungi. 2021; 7(6):424. https://doi.org/10.3390/jof7060424

Santos, André L. S., Lys A. Braga-Silva, Diego S. Gonçalves, Lívia S. Ramos, Simone S. C. Oliveira, Lucieri O. P. Souza, Vanessa S. Oliveira, Roberto D. Lins, Marcia R. Pinto, Julian E. Muñoz, and et al. 2021. "Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches" Journal of Fungi 7, no. 6: 424. https://doi.org/10.3390/jof7060424

Santos, A. L. S., Braga-Silva, L. A., Gonçalves, D. S., Ramos, L. S., Oliveira, S. S. C., Souza, L. O. P., Oliveira, V. S., Lins, R. D., Pinto, M. R., Muñoz, J. E., Taborda, C. P., & Branquinha, M. H. (2021). Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches. Journal of Fungi, 7(6), 424. https://doi.org/10.3390/jof7060424